$0.70
0[0.00%]
At close: Apr 18
$0.70
0[0.00%]
After Hours: 6:31PM EDT
Chemomab Therapeutics
(NASDAQ:CMMB)Chemomab Therapeutics Stock (NASDAQ:CMMB), Quotes and News Summary
Chemomab Therapeutics Stock (NASDAQ: CMMB) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 221.308K |
| Day Range | - - - |
| 52 Wk Range | 0.420 - 1.890 |
| Market Cap | $9.943M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 1.58% |
| Days to Cover | 2.79 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Chemomab Therapeutics Ltd
Sector
Health Care
Industry
Biotechnology
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and develop...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Chemomab Therapeutics (CMMB) stock?
You can purchase shares of Chemomab Therapeutics (NASDAQ: CMMB) through any online brokerage.
Who are Chemomab Therapeutics's (CMMB) competitors?
Other companies in Chemomab Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX), Longeveron (NASDAQ:LGVN) and Trevena (NASDAQ:TRVN).
What is the target price for Chemomab Therapeutics (CMMB) stock?
The latest price target for Chemomab Therapeutics (NASDAQ: CMMB) was reported by Oppenheimer on Friday, March 8, 2024. The analyst firm set a price target for 0.00 expecting CMMB to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Chemomab Therapeutics (CMMB)?
The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $0.7 last updated April 18, 2024 at 6:31 PM EDT.
Does Chemomab Therapeutics (CMMB) pay a dividend?
There are no upcoming dividends for Chemomab Therapeutics.
When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?
Chemomab Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Chemomab Therapeutics (CMMB) going to split?
There is no upcoming split for Chemomab Therapeutics.
What sector and industry does Chemomab Therapeutics (CMMB) operate in?
Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.